Vanda Pharmaceuticals (VNDA) Reaches Settlement with Novartis AG

Shares of Vanda Pharmaceuticals Inc. (VNDA) were up +2.09 or +17.55 percent to $14.00 per share in premarket trading this morning, after the company announced yesterday after the close that it had reached an agreement with Novartis AG (NVS) in ongoing arbitration proceedings on licensing for Fanapt. Vanda Pharmaceuticals stock closed at $11.91 per share, Read the full article... Read the rest of Vanda Pharmaceuticals (VNDA) Reaches Settlement with Novartis AG at InvestorGuide.com .